ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Markets/EquitiesArticle

UBS downgrades Aryzta to 'Sell', shares hit four-year low

Swiss bakery group Aryzta's stock plunged 8.3% after UBS cut its rating to 'Sell' and slashed its price target to 40 francs. The downgrade follows weak first-half results and a review of the German business.

PA
Priya Anand · Equities & Earnings Desk · 21 Aug 2026 · 16:40 · 1 min read
Share
UBS downgrades Aryzta to 'Sell', shares hit four-year low

Shares of Aryzta, the Swiss bakery group, fell 8.3% to 41 francs on Thursday, marking the lowest level in nearly four years, as UBS delivered a double downgrade to the company's stock.

The bank reduced its rating from 'Buy' to 'Sell' and cut its 12-month price target from 70 francs to 40 francs, implying a 4% downside. UBS also forecast stagnant or slightly declining organic growth from fiscal 2026 onward, citing a weak consumer environment that could erode pricing power. Rising competition and potential expansion of in-house production by a major customer were cited as additional headwinds.

Aryzta's first-half 2026 results, published 10 days prior, showed a decline in both revenue and profit, driven primarily by its German operations. The company has launched a comprehensive review of the German business, evaluating 'all options' to address the challenges. The stock has since lost nearly 16% over two trading sessions.

Following the results, analyst estimates have been revised downward. Seven analysts now cover the stock, with two—UBS and Kepler Cheuvreux—assigning a 'Sell' rating. All seven have reduced their price targets, bringing the average to 60 francs from 75 francs 11 days ago. Five analysts still recommend buying the shares, while two advise selling.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
ADVERTISEMENT